tirzepatide name in mexico NICE recommends Lilly's for type 2 diabetes treatment Tirzepatide - Weightloss Medicine
Description
The pharmaceutical landscape is once again at the center of a legal battle
Background Over the coming years, the market for anti-obesity medicines (AOMs), including glucagon-like peptide-1 (GLP-1) receptor agonists, is projected to grow more rapidly in ex-US markets than in the US
Insurance coverage for GLP-1 medications varies by condition and plan
This was prompted by the publication of a landmark article in the New England Journal of Medicine addressing the impact of this medication in a large clinical trial
